Needham & Company Initiates Coverage on BP; Consensus Rating is 'Moderate Buy'
1 report, 1 independent
Updated Oct 8
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company initiated coverage on BP shares, setting a "hold" rating. MarketBeat reported that BP has a consensus rating of "Moderate Buy" with a consensus target price of $48.44. BP shares opened at $46.04 on Thursday, following a previous close of $44.51.
From themarketsdaily.com
Why it matters
The coverage and consensus ratings reflect ongoing market activity surrounding the oil and gas company. BP recently reported quarterly earnings of $2.22 per share, which exceeded the consensus estimate of $1.87.
From themarketsdaily.com
Who's involved
- BPBritish multinational oil and gas company
- Needham & CompanyInvestment bank that initiated coverage on BP
- MarketBeatPlatform that provides consensus rating data for BP
Keep exploring
The entities involved
-
BP
British multinational oil and gas company
-
Needham & Company
American independent investment bank and asset management firm
-
MarketBeat
American personal finance blog
Related events
- MarketBeat provided average ratings and consensus target prices for Pacira BioSciences, while Needham and Royal Bank of Canada issued rating updates.
- MarketBeat provided average ratings and target prices, while Jefferies Financial Group began coverage with a buy rating for Crane NXT.
- MarketBeat reports on company ratings and targets for Nikon Corporation and Jabil, comparing business profiles and financial health.
- MarketBeat is reporting on consensus ratings for Aehr Test Systems, a company whose stock trades on the Nasdaq exchange.
- MarketBeat provided average rating data for the stock, and Citigroup began coverage on Whitehawk Therapeutics shares.